LabCompass

Timothy Chen

Medicine · The Ohio State University

Established · publishing since 1982Rising activity

Publications

26

Citations

561

Est. group size

~4

Recurring co-author estimate

Active years

45

Publishing since 1982

Research summary
AI-generated

The publication record under this name spans several distinct areas, including smoking cessation and treatment engagement, psychiatric care (electroconvulsive therapy and pharmacogenomic-guided antidepressant prescribing), gastroenterology (bariatric surgery outcomes, pylorus disorders), cancer immunotherapy, and cardiac tissue engineering. Because these topics are quite disparate, the publication list may represent contributions to multiple collaborative projects across different clinical and laboratory domains rather than a single focused research program. Prospective students should note that the data does not point to one coherent specialty but rather a mix of clinical and translational research outputs.

Smoking cessation and tobacco treatmentPsychiatric treatment (depression, electroconvulsive therapy)Gastroenterology (bariatric surgery, pylorus disorders)Cancer immunotherapy (checkpoint inhibitors)Cardiac tissue engineering

Publication output was minimal or absent in the middle of the decade (2020-2022) but has increased in recent years, with a notable rise in 2023 and 2026.

Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026

Publication cadence
Publications per year over the last 10 years — averaging 2.0/year recently
172018: 2 publications182019: 1 publication192021222023: 3 publications232024: 2 publications242025: 1 publication252026: 4 publications426
Publishes in
  • Blood×2
  • Gastroenterology×2
  • Nature Protocols×1
  • Blood Cancer Journal×1
  • Nicotine & Tobacco Research×1
Similar researchers
By research-topic overlap

This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.

Last updated Jul 19, 2026.

Claim or correct this profile